Clinical Trials Browser

Unknown × INDUSTRY × Vemurafenib × Clear all

NCT03781219 2023-05-31

A PhaseI Study of HL-085 Plus Vemurafenib in Solid Tumor With BRAF V600 Mutation

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05233332 2023-05-31

mCRC

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT05263453 2023-05-31

HL-085+Vemurafenib to Treat Advanced Melanoma Patients With BRAF V600E/K Mutation

Phase 2 Unknown

Melanoma